Clinical inertia and blood pressure goal attainment

Journal of Clinical Hypertension

Volumn 11, Issue SUPPL. 1, 2009, Pages

  Basile, Jan ^a  

^a RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; THIAZIDE DIURETIC AGENT;

AGE DISTRIBUTION; ALGORITHM; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; COMORBIDITY; DECISION SUPPORT SYSTEM; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DRUG DOSE COMPARISON; DRUG MEGADOSE; DYSLIPIDEMIA; EDUCATION PROGRAM; ETHNICITY; HEALTH BELIEF; HEALTH CARE QUALITY; HEART INFARCTION; HOME MONITORING; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LOW DRUG DOSE; MONOTHERAPY; MOTIVATION; PERFORMANCE MEASUREMENT SYSTEM; PHARMACEUTICAL CARE; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; SYSTOLIC BLOOD PRESSURE; TREATMENT RESPONSE;

EID: 71149088980     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1751-7176.2009.00210.x     Document Type: Review

References (22)

1. Neal B, MacMahon S, Chapman N. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomized trials. Lancet 2000, 356:1955-1964. Blood Pressure Lowering Treatment Trialists' Collaboration
2. Chobanian AV, Bakris GL, Black HR. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA 2003, 289:2560-2572. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee
3. Rosendorff C, Black HR, Cannon CP. Treatment of hypertension in the prevention and management of ischemic heart disease. A Scientific Statement from the American Heart Association. Circulation 2007, 115:2761-2788. American Heart Association Council for High Blood Pressure Research; American Heart Association Council on Clinical Cardiology; American Heart Association Council on Epidemiology and Prevention
4. Ong KL, Cheung BM, Man YB. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension 2007, 49:69-75.
5. Steinman MA, Fischer MA, Shlipak MG. Clinician awareness of adherence to hypertension guidelines. Am J Med 2004, 117:747-754.
6. Phillips LS, Branch WT, Cook CB. Clinical inertia. Ann Intern Med 2001, 135:825-834.
7. Berlowitz DR, Ash AS, Hickey EC. Inadequate management of blood pressure in a hypertensive population. N Engl J Med 1998, 339:1957-1963.
8. Oliveria SA, Lapuerta P, McCarthy BD. Physician-related barriers to the effective management of uncontrolled hypertension. Arch Intern Med 2002, 162:413-420.
9. Okonofua EC, Simpson KN, Jesri A. Therapeutic inertia is an impediment to achieving the healthy people 2010 blood pressure control goals. Hypertension 2006, 47:345-351.
10. Mosca L, Linfante AH, Benjamin EJ. National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation 2005, 111:499-510.
11. Andrade SE, Gurwitz JH, Field TS. Hypertension management: the care gap between clinical guidelines and clinical practice. Am J Manag Care 2004, 10:481-486.
12. Burt VL, Whelton P, Roccella EJ. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population: data from the health examination surveys, 1960 to 1991. Hypertension 1995, 26:60-69.
13. Petersen L, Woodard LD, Henderson LM. Will hypertension performance measures used for pay-for-performance programs penalize those who care for medically complex patients?. Circulation 2009, 119:2978-2985.
14. Ross S, Walker A, MacLeod MJ. Patient compliance in hypertension: role of illness perceptions and treatment beliefs. J Hum Hypertens 2004, 18:607-613.
15. Horne R, Clatworthy J, Polmear A. Do hypertensive patients' beliefs about their illness and treatment influence medication adherence and quality of life?. J Hum Hypertens 2001, 15(suppl 1):S65-S68. Anglo-Scandinavian Cardiac Outcomes Trial
16. Carter BL, Bergus GR, Dawson JD. A cluster randomized trial to evaluate physician/pharmacist collaboration to improve blood pressure control. J Clin Hypertens (Greenwich) 2008, 10:260-271.
17. Egan BM, Lackland DT, Igho-Pemu P. Cardiovascular risk factor control in communities-update from the ASH Carolinas-Georgia chapter, the hypertension initiative, and the community physicians' network. J Clin Hypertens (Greenwich) 2006, 8:879-886.
18. Cushman W, Ford CE, Cutler JA. Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). J Clin Hypertens 2002, 4:393-404. ALLHAT Collaborative Research Group
19. Jamerson K, Bakris GL, Dahlöf B. Exceptional early blood pressure control rates: the ACCOMPLISH trial. Blood Press 2007, 16:80-86. ACCOMPLISH Investigators
20. Mahmud A, Feely J. Low-dose quadruple antihypertensive combination: more efficacious than individual agents-a preliminary report. Hypertension 2007, 49:272-275.
21. Feldman R, Zou GY, Vandervoort MK. A simplified approach to the treatment of uncomplicated hypertension: a cluster randomized, controlled trial. Hypertension 2009, 53:646-653.
22. Cushman WC, Basile J. Achieving blood pressure goals: why aren't we?. J Clin Hypertens (Greenwich) 2006, 8:865-872.